ATI Physical Therapy, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD; shares in millions, except per-share amounts

	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021	Q2 FY2021 As of Jun 30, 2021	Q1 FY2021 As of Mar 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q3 FY2020 As of Sep 30, 2020	Q2 FY2020 As of Jun 30, 2020
Assets:
Current assets:
Cash
Cash and cash equivalents
Accounts receivable (net of allowance for doubtful accounts of $43,327 and $48,055 at December 31, 2024 and December 31, 2023, respectively)
Prepaid expenses
Insurance recovery receivable
Other current assets
Assets held for sale
Total current assets

Deferred offering costs
Investments held in Trust Account
Property and equipment, net
Operating lease right-of-use assets
Goodwill, net
Trade name and other intangible assets, net
Other non-current assets
Total assets

Liabilities, Mezzanine Equity and Stockholders' Equity:
Current liabilities:
Accounts payable and accrued expenses
Franchise tax payable
Accounts payable
Accrued expenses and other liabilities
Current portion of operating lease liabilities
Current portion of long-term debt
Liabilities held for sale
Total current liabilities

Deferred underwriting commissions payable
Warrant liabilities
Redeemable preferred stock
Long-term debt, net
2L Notes due to related parties, at fair value
Warrant liability
Contingent common shares liability
Deferred income tax liabilities
Operating lease liabilities
Other non-current liabilities
Total liabilities
Series A Senior Preferred Stock, $0.0001 par value; 1.0 million shares authorized; 0.2 million shares issued and outstanding; $1,407.65 stated value per share at December 31, 2024; $1,249.06 stated value per share at December 31, 2023
Common Class A
Total series A Senior Preferred Stock, $0.0001 par value; 1.0 million shares authorized; 0.2 million shares issued and outstanding; $1,407.65 stated value per share at December 31, 2024; $1,249.06 stated value per share at December 31, 2023

Stockholders' equity:
Preferred stock, $0.0001 par value; 1.0 million shares authorized; none issued and outstanding at December 31, 2021 and December 31, 2020
Class A common stock, $0.0001 par value; 470.0 million shares authorized; 4.5 million shares issued, 4.2 million shares outstanding at December 31, 2024; 4.2 million shares issued, 4.0 million shares outstanding at December 31, 2023
Common Class A
Common Class F
Total class A common stock, $0.0001 par value; 470.0 million shares authorized; 4.5 million shares issued, 4.2 million shares outstanding at December 31, 2024; 4.2 million shares issued, 4.0 million shares outstanding at December 31, 2023

Treasury stock (in shares)
Treasury stock, at cost, 0.05 million shares and 0.03 million shares at June 30, 2022 and December 31, 2021, respectively
Treasury stock, at cost, 0.092 million shares and 0.007 million shares at December 31, 2024 and December 31, 2023, respectively
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
ATI Physical Therapy, Inc. equity
Common Class F
Total ATI Physical Therapy, Inc. equity

Non-controlling interests
Total stockholders' equity

Total liabilities, mezzanine equity and stockholders' equity

Preferred stock, stated value (dollars per share)
Preferred stock, shares issued (in shares)
Common Class A
Total preferred stock, shares issued (in shares)

Comments